Pulmonary rehabilitation: An overview including new and innovative strategies

Minerva Pneumologica

Volumn 50, Issue 1, 2011, Pages 47-61

  Evans, R A ^a   Goldstein, R S ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Lung diseases; Rehabilitation; Respiratory tract diseases

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; CREATINE; TESTOSTERONE;

AEROBIC EXERCISE; BRADYPNEA; CACHEXIA; CARDIOPULMONARY EXERCISE TEST; CARDIOPULMONARY FUNCTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY QUESTIONNAIRE; COMORBIDITY; COST EFFECTIVENESS ANALYSIS; DYSPNEA; ENDURANCE SHUTTLE WALK TEST; ENDURANCE TRAINING; EXERCISE; EXERCISE INTENSITY; EXERCISE TOLERANCE; FOLLOW UP; GOLD STANDARD; HEALTH CARE COST; HEALTH EDUCATION; HEALTH STATUS; HEART FAILURE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INCREMENTAL SHUTTLE WALK TEST; LEG EXERCISE; LUNG FIBROSIS; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PHYSICAL CAPACITY; PHYSICAL TOLERANCE; PSYCHOLOGICAL ASPECT; PULMONARY REHABILITATION; QUALITY CONTROL; QUALITY OF LIFE; QUESTIONNAIRE; RESISTANCE TRAINING; REVIEW; RISK ASSESSMENT; SELF CARE; SHORT FORM 36; SIX MINUTE WALK TEST; ST GEORGE RESPIRATORY QUESTIONNAIRE; SUPPLEMENTATION; WALKING AID; WALKING SPEED;

EID: 79957600880     PISSN: 00264954     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (104)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001;163:1256-76. (Pubitemid 32378468)
2. Agusti A, Soriano JB. COPD as a systemic disease. COPD 2008;5:133-8. (Pubitemid 351549834)
3. Maltais F, LeBlanc P, Jobin J, Casaburi R. Peripheral muscle dysfunction in chronic obstructive pulmonary disease. Clin Chest Med 2000;21:665-77. (Pubitemid 32057585)
4. Schols AM. Nutrition in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2000;6:110-5.
5. Ionescu AA, Schoon E. Osteoporosis in chronic obstructive pulmonary disease. Eur Respir J Suppl 2003;46:64s-75s.
6. Van Vliet M, Spruit MA, Verleden G, Kasran A, Van Herck E, Pitta F et al. Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:1105-11. (Pubitemid 43066645)
7. Similowski T, Agusti A, MacNee W, Schonhofer B. The potential impact of anaemia of chronic disease in COPD. Eur Respir J 2006;27:390-6. (Pubitemid 43180920)
8. Hill K, Geist R, Goldstein RS, Lacasse Y. Anxiety and depression in end-stage COPD. Eur Respir J 2008;31:667-77.
9. Gosselink R, Troosters T, Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med 1996;153:976-80.
10. Bernard S, LeBlanc P, Whittom F, Carrier G, Jobin J, Belleau R et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-34. (Pubitemid 28378196)
11. Maltais F, Sullivan MJ, LeBlanc P, Duscha BD, Schachat FH, Simard C et al. Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur Respir J 1999;13:850-4.
12. Maltais F, Simard AA, Simard C, Jobin J, Desgagnes P, LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med 1996;153:288-93. (Pubitemid 26026864)
13. Gosker HR, Hesselink MK, Duimel H, Ward KA, Schols AM. Reduced mitochondrial density in the vastus lateralis muscle of patients with COPD. Eur Respir J 2007;30:73-9. (Pubitemid 47074009)
14. Steiner MC, Evans R, Deacon SJ, Singh SJ, Patel P, Fox J et al. Adenine nucleotide loss in the skeletal muscles during exercise in chronic obstructive pulmonary disease. Thorax 2005;60:932-6. (Pubitemid 41598208)
15. Man WD, Soliman MG, Nikoletou D, Harris ML, Rafferty GF, Mustfa N et al. Non-volitional assessment of skeletal muscle strength in patients with chronic obstructive pulmonary disease. Thorax 2003;58:665-9.
16. Franssen FM, Wouters EF, Schols AM. The contribution of starvation, deconditioning and ageing to the observed alterations in peripheral skeletal muscle in chronic organ diseases. Clin Nutr 2002;21:1-14. (Pubitemid 34257506)
17. Remels AH, Gosker HR, van d, V, Langen RC, Schols AM. Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity. Clin Chest Med 2007;28:537-52, vi.
18. Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 2007;167:60-7. (Pubitemid 46072408)
19. Kim HF, Kunik ME, Molinari VA, Hillman SL, Lalani S, Orengo CA et al. Functional impairment in COPD patients: the impact of anxiety and depression. Psychosomatics 2000;41:465-71.
20. Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, Bourbeau J et al. American Thoracic Society/European Respiratory Society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 2006;173:1390-413.
21. Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, Mahler DA et al. Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest 2007;131(5 Suppl):4S-42S.
22. NICE COPD guidelines. [cited 2010 January 18]. Available at: http://guidance.nice.org.uk/CG101.
23. Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet 2000; 355:362-8.
24. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest 2002;121:1434-40.
25. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med 2003;167:544-9.
26. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008;63:549-54.
27. Newall C, Stockley RA, Hill SL. Exercise training and inspiratory muscle training in patients with bronchiectasis. Thorax 2005;60:943-8.
28. Sahlberg M, Eriksson BO, Sixt R, Strandvik B. Cardiopulmonary data in response to 6 months of training in physically active adult patients with classic cystic fibrosis. Respiration 2008;76:413-20.
29. Ram FS, Robinson SM, Black PN, Picot J. Physical training for asthma. Cochrane Database Syst Rev 2005;(4):CD001116.
30. Mereles D, Ehlken N, Kreuscher S, Ghofrani S, Hoeper MM, Halank M et al. Exercise and respiratory training improve exercise capacity and quality of life in patients with severe chronic pulmonary hypertension. Circulation 2006;114:1482-9.
31. Munro PE, Holland AE, Bailey M, Button BM, Snell GI. Pulmonary rehabilitation following lung transplantation. Transplant Proc 2009;41:292-5.
32. Gosker HR, Wouters EF, van der Vusse GJ, Schols AM. Skeletal muscle dysfunction in chronic obstructive pulmonary disease and chronic heart failure: underlying mechanisms and therapy perspectives. Am J Clin Nutr 2000;71:1033-47.
33. Gosker HR, Lencer NH, Franssen FM, van der Vusse GJ, Wouters EF, Schols AM. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest 2003;123:1416-24.
34. Belardinelli R, Georgiou D, Cianci G, Purcaro A. Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 1999;99:1173-82.
35. Davies EJ, Moxham T, Rees K, Singh S, Coats AJ, Ebrahim S et al. Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis. Eur J Heart Fail 2010;12:706-15.
36. van Tol BA, Huijsmans RJ, Kroon DW, Schothorst M, Kwakkel G. Effects of exercise training on cardiac performance, exercise capacity and quality of life in patients with heart failure: a meta-analysis. Eur J Heart Fail 2006;8:841-50.
37. O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, Ellis SJ et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 2009;301:1439-50.
38. Evans RA, Singh SJ, Collier R, Loke I, Steiner MC, Morgan MD. Generic, symptom based, exercise rehabilitation; integrating patients with COPD and heart failure. Respir Med 2010;104:1473-81.
39. Fletcher RCM, Elmes PC, Fairbairn AS, Wood CH. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J 1959;2:257-66.
40. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999;54:581-6.
41. Evans RA, Singh SJ, Collier R, Williams JE, Morgan MD. Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med 2009;103:1070-5.
42. Brooks D, Sottana R, Bell B, Hanna M, Laframboise L, Selvanayagarajah S et al. Characterization of pulmonary rehabilitation programs in Canada in 2005. Can Respir J 2007;14:87-92.
43. Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease: a clinical trial. Nocturnal Oxygen Therapy Trial Group. Ann Intern Med 1980;93:391-8.
44. Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema. Report of the Medical Research Council Working Party. Lancet 1981;1:681-6.
45. Bradley JM, Lasserson T, Elborn S, Macmahon J, O'Neill B. A systematic review of randomized controlled trials examining the short-term benefit of ambulatory oxygen in COPD. Chest 2007;131:278-85.
46. Garrod R, Paul EA, Wedzicha JA. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax 2000;55:539-43.
47. Nonoyama ML, Brooks D, Lacasse Y, Guyatt GH, Goldstein RS. Oxygen therapy during exercise training in chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007;(2):CD005372.
48. Sandland CJ, Morgan MD, Singh SJ. Detecting oxygen desaturation in patients with COPD: incremental versus endurance shuttle walking. Respir Med 2008;102:1148-52.
49. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111-7.
50. Bansal V, Hill K, Dolmage TE, Brooks D, Woon LJ, Goldstein RS. Modifying track layout from straight to circular has a modest effect on the 6-min walk distance. Chest 2008;133:1155-60.
51. Enright PL, Sherrill DL. Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med 1998;158(5 Pt 1):1384-7.
52. Casas A, Vilaro J, Rabinovich R, Mayer A, Barbera JA, Rodriguez-Roisin R et al. Encouraged 6-min walking test indicates maximum sustainable exercise in COPD patients. Chest 2005;128:55-61.
53. Troosters T, Vilaro J, Rabinovich R, Casas A, Barbera JA, Rodriguez-Roisin R et al. Physiological responses to the 6-min walk test in patients with chronic obstructive pulmonary disease. Eur Respir J 2002;20:564-9.
54. Celli BR, Cote CG, Marin JM, Casanova C, Montes dO, Mendez RA et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
55. Singh SJ, Morgan MD, Hardman AE, Rowe C, Bardsley PA. Comparison of oxygen uptake during a conventional treadmill test and the shuttle walking test in chronic airflow limitation. Eur Respir J 1994;7:2016-20.
56. Dyer CA, Singh SJ, Stockley RA, Sinclair AJ, Hill SL. The incremental shuttle walking test in elderly people with chronic airflow limitation. Thorax 2002;57:34-8.
57. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992;47:1019-24.
58. Revill SM, Morgan MD, Singh SJ, Williams J, Hardman AE. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax 1999;54:213-22.
59. Pepin V, Brodeur J, Lacasse Y, Milot J, LeBlanc P, Whittom F et al. Six-minute walking versus shuttle walking: responsiveness to bronchodilation in chronic obstructive pulmonary disease. Thorax 2007;62:291-8.
60. Brouillard C, Pepin V, Milot J, Lacasse Y, Maltais F. Endurance shuttle walking test: responsiveness to salmeterol in COPD. Eur Respir J 2008;31:579-84.
61. Schunemann HJ, Goldstein R, Mador MJ, McKim D, Stahl E, Puhan M et al. A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J 2005;25:31-40.
62. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992;145:1321-7.
63. Puhan MA, Guyatt GH, Goldstein R, Mador J, McKim D, Stahl E et al. Relative responsiveness of the Chronic Respiratory Questionnaire, St. Georges Respiratory Questionnaire and four other health-related quality of life instalments for patients with chronic lung disease. Respir Med 2007;101:308-16.
64. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest 1988;93:580-6.
65. Mahler DA, Waterman LA, Ward J, McCusker C, Zuwallack R, Baird JC. Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes. Chest 2007;132:1283-90.
66. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002;52:69-77.
67. Kunik ME, Azzam PN, Souchek J, Cully JA, Wray NP, Krishnan LL et al. A practical screening tool for anxiety and depression in patients with chronic breathing disorders. Psychosomatics 2007;48:16-21.
68. Puhan MA, Mador MJ, Held U, Goldstein R, Guyatt GH, Schunemann HJ. Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J 2008;32:637-43.
69. Singh SJ, Jones P, Evans R, Morgan M. The minimum clinically important improvement for the Incremental Shuttle Walking Test. Thorax 2008;63:775-7.
70. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407-15.
71. Schunemann HJ, Griffith L, Jaeschke R, Goldstein R, Stubbing D, Guyatt GH. Evaluation of the minimal important difference for the feeling thermometer and the St. George's Respiratory Questionnaire in patients with chronic airflow obstruction. J Clin Epidemiol 2003;56:1170-6.
72. Vallet G, Ahmaidi S, Serres I, Fabre C, Bourgouin D, Desplan J et al. Comparison of two training programmes in chronic airway limitation patients: standardized versus individualized protocols. Eur Respir J 1997;10:114-22.
73. Beauchamp MK, Nonoyama M, Goldstein RS, Hill K, Dolmage TE, Mathur S et al. Interval versus continuous training in individuals with chronic obstructive pulmonary disease - a systematic review. Thorax 2010;65:157-64.
74. Mador MJ, Bozkanat E, Aggarwal A, Shaffer M, Kufel TJ. Endurance and strength training in patients with COPD. Chest 2004;125:2036-45.
75. Janaudis-Ferreira T, Hill K, Goldstein R, Wadell K, Brooks D. Arm exercise training in patients with chronic obstructive pulmonary disease: a systematic review. J Cardiopulm Rehabil Prev 2009;29:277-83.
76. Janaudis-Ferreira T, Hill K, Goldstein RS, Robles-Ribeiro P, Beauchamp MK, Dolmage TE et al. Resistance arm training in patients with chronic obstructive pulmonary disease: a randomized controlled trial. Chest 2010 [In press].
77. Paz-Diaz H, Montes dO, Lopez JM, Celli BR. Pulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPD. Am J Phys Med Rehabil 2007;86:30-6.
78. Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R et al. Reduction of hospital utilization in patients with chronic obstaictive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003;163:585-91.
79. Troosters T, Casaburi R, Gosselink R, Decramer M. Pulmonary rehabilitation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2005;172:19-38.
80. Sewell L, Singh SJ, Williams JE, Collier R, Morgan MD. How long should outpatient pulmonary rehabilitation be? A randomised controlled trial of 4 weeks versus 7 weeks. Thorax 2006;61:767-71.
81. Verrill D, Barton C, Beasley W, Lippard WM. The effects of short-term and long-term pulmonary rehabilitation on functional capacity, perceived dyspnea, and quality of life. Chest 2005;128:673-83.
82. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007;131:696-704.
83. Ringbaek T, Brondum E, Martinez G, Thogersen J, Lange P. Long-term effects of 1-year maintenance training on physical functioning and health status in patients with COPD: A randomized controlled study. J Cardiopulm Rehabil Prev 2010;30:47-52.
84. Ries AL, Kaplan RM, Myers R, Prewitt LM. Maintenance after pulmonary rehabilitation in chronic lung disease: a randomized trial. Am J Respir Crit Care Med 2003;167:880-8.
85. Cockram J, Cecins N, Jenkins S. Maintaining exercise capacity and quality of life following pulmonary rehabilitation. Respirology 2006;11:98-104.
86. Foglio K, Bianchi L, Ambrosino N. Is it really useful to repeat outpatient pulmonary rehabilitation programs in patients with chronic airway obstruction? A 2-year controlled study. Chest 2001;119:1696-704.
87. Probst VS, Troosters T, Coosemans I, Spruit MA, Pitta FO, Decramer M et al. Mechanisms of improvement in exercise capacity using a rollator in patients with COPD. Chest 2004;126:1102-7.
88. Gupta R, Goldstein R, Brooks D. The acute effects of a rollator in individuals with COPD. J Cardiopulm Rehabil 2006;26:107-11.
89. British Thoracic Society Standards of Care Subcommittee on Pulmonary Rehabilitation. Pulmonary rehabilitation. Thorax 2001;56:827-34.
90. van Wetering CR, Hoogendoorn M, Mol SJ, Ruttenvan Molken MP, Schols AM. Short- and long-term efficacy of a community-based COPD management programme in less advanced COPD: a randomised controlled trial. Thorax 2010;65:7-13.
91. Maltais F, Bourbeau J, Shapiro S, Lacasse Y, Perrault H, Baltzan M et al. Effects of home-based pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2008;149:869-78.
92. Cote CG, Dordelly LJ, Celli BR. Impact of COPD exacerbations on patient-centered outcomes. Chest 2007;131:696-704.
93. Spruit MA, Gosselink R, Troosters T, Kasran A, Gayan-Ramirez G, Bogaerts P et al. Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I. Thorax 2003;58:752-6.
94. Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R. Physical activity and hospitalization for exacerbation of COPD. Chest 2006;129:536-44.
95. Man WD, Polkey MI, Donaldson N, Gray BJ, Moxham J. Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: randomised controlled study. BMJ 2004;329:1209.
96. Seymour JM, Moore L, Jolley CJ, Ward K, Creasey J, Steier JS et al. Outpatient pulmonary rehabilitation following acute exacerbations of COPD. Thorax 2010;65:423-8.
97. Steiner MC, Barton RL, Singh SJ, Morgan MD. Nutritional enhancement of exercise performance in chronic obstructive pulmonary disease: a randomised controlled trial. Thorax 2003;58:745-51.
98. Deacon SJ, Vincent EE, Greenhaff PL, Fox J, Steiner MC, Singh SJ et al. Randomized controlled trial of dietary creatine as an adjunct therapy to physical training in chronic obstaictive pulmonary disease. Am J Respir Crit Care Med 2008;178:233-9.
99. Casaburi R, Bhasin S, Cosentino L, Porszasz J, Somfay A, Lewis MI et al. Effects of testosterone and resistance training in men with chronic obstaictive pulmonary disease. Am J Respir Crit Care Med 2004;170:870-8.
100. Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005;127:809-17.
101. Hawkins P, Johnson LC, Nikoletou D, Hamnegard CH, Sherwood R, Polkey MI et al. Proportional assist ventilation as an aid to exercise training in severe chronic obstaictive pulmonary disease. Thorax 2002;57:853-59.
102. Eves ND, Sandmeyer LC, Wong EY, Jones LW, MacDonald GF, Ford GT et al. Helium-hyperoxia: a novel intervention to improve the benefits of pulmonary rehabilitation for patients with COPD. Chest 2009;135:609-18.
103. Dolmage TE, Goldstein RS. Response to one-legged cycling in patients with COPD. Chest 2006;129:325-32.
104. Dolmage TE, Goldstein RS. Effects of one-legged exercise training of patients with COPD. Chest 2008;133:370-6.